-
NMPA signs letter of intent on cooperation with Danish Medicines Agency
2024-11-04
Li Li, commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices in Beijing on Oct 24.
-
Li Li meets with head of Brazil’s Health Regulatory Agency
2024-11-04
Li Li, commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Antonio Barra Torres, head of Brazil's Health Regulatory Agency (Anvisa), in Beijing on Oct 21.
-
China plans credit system to curb medical insurance misuse
2024-09-29
China issued a guideline on Friday on developing a credit system for hospital and pharmacy personnel certified to process medical insurance funds in order to strengthen supervision.
-
Big push for homegrown innovative medicines
2024-09-27
The National Medical Products Administration, China's top drug regulator, says it will redouble efforts to facilitate research and market registration of homegrown innovative drugs, while speeding up the introduction of novel foreign drugs to the domestic market to meet public demand.
-
Huang Guo meets with Danish ambassador to China
2024-09-20
On Sept 10, Huang Guo, deputy commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Michael Starbaek Christensen, Danish ambassador to China.
-
China to allow wholly foreign-owned hospitals in certain areas
2024-09-12
China plans to allow the establishment of wholly foreign-owned hospitals in certain cities and regions across the country, according to an official document unveiled on Sunday.
